(Total Views: 277)
Posted On: 03/23/2018 6:49:34 PM
Post# of 36159
QBL 3 month update of MMJ and Hemp incl links.
Targeting Premium DSO Bauxite 2018 and start operations this year.
https://docs.wixstatic.com/ugd/1943b6_8e1d784...012acb.pdf
QBL Quarterly report december 2017; https://www.queenslandbauxite.com/single-post...T-DEC-2017
QBL Emerging as a keyplayer in Medical Cannabis; https://www.queenslandbauxite.com/single-post...abis-scene
January 8, 2018
• VitaCann Pty Ltd (“VitaCann” subsidairy) has signed an exclusive joint venture agreement (the “Joint Venture”) for a World First Pharmaceutical Grade Medical Cannabis Extended Release Pill with Canntab Therapeutics Limited (“Canntab”) of Toronto,Canada.,
Readmore;https://docs.wixstatic.com/ugd/1943b6_c0073175f4c2485eb7de609e622f50ca.pdf
Breakthrough for GMP Quality Medicinal Cannabis
December 11, 2017
The Board at Queensland Bauxite (ASX:QBL) is excited with the recent success and progress of its investment in Medical Cannabis Ltd (“MCL” or “the Company”), particularly as the medicinal focused arm of that Company, Vitacann, has signed a Letter of Intent for a joint venture subject to full documentation with an Israeli recommended group of North American chemists who have put together what we understand to be a world first in the Medical Cannabis industry. Read More;
https://docs.wixstatic.com/ugd/1943b6_6e8e6bb...457cdc.pdf
MCL (subsidiary to QBL), dec 27, Escalates Hemp Seed Production.
https://www.queenslandbauxite.com/single-post...Production
MCL and AEB join to develop Cannabis veterinary medications; The Boards of Queensland Bauxite Limited (ASX:QBL) and Algae.Tec Ltd (ASX:AEB) are delighted to announce a significant Australian ground breaking agreement whereby AEB will exclusively license Medical Cannabis Limited’s Low THC Delta 9 Cannabis cultivars from the uniqu...
https://www.queenslandbauxite.com/single-post...edications
Read More: https://investorshangout.com/post/view?id=496...z5AcAA6sPD
Targeting Premium DSO Bauxite 2018 and start operations this year.
https://docs.wixstatic.com/ugd/1943b6_8e1d784...012acb.pdf
QBL Quarterly report december 2017; https://www.queenslandbauxite.com/single-post...T-DEC-2017
QBL Emerging as a keyplayer in Medical Cannabis; https://www.queenslandbauxite.com/single-post...abis-scene
January 8, 2018
• VitaCann Pty Ltd (“VitaCann” subsidairy) has signed an exclusive joint venture agreement (the “Joint Venture”) for a World First Pharmaceutical Grade Medical Cannabis Extended Release Pill with Canntab Therapeutics Limited (“Canntab”) of Toronto,Canada.,
Readmore;https://docs.wixstatic.com/ugd/1943b6_c0073175f4c2485eb7de609e622f50ca.pdf
Breakthrough for GMP Quality Medicinal Cannabis
December 11, 2017
The Board at Queensland Bauxite (ASX:QBL) is excited with the recent success and progress of its investment in Medical Cannabis Ltd (“MCL” or “the Company”), particularly as the medicinal focused arm of that Company, Vitacann, has signed a Letter of Intent for a joint venture subject to full documentation with an Israeli recommended group of North American chemists who have put together what we understand to be a world first in the Medical Cannabis industry. Read More;
https://docs.wixstatic.com/ugd/1943b6_6e8e6bb...457cdc.pdf
MCL (subsidiary to QBL), dec 27, Escalates Hemp Seed Production.
https://www.queenslandbauxite.com/single-post...Production
MCL and AEB join to develop Cannabis veterinary medications; The Boards of Queensland Bauxite Limited (ASX:QBL) and Algae.Tec Ltd (ASX:AEB) are delighted to announce a significant Australian ground breaking agreement whereby AEB will exclusively license Medical Cannabis Limited’s Low THC Delta 9 Cannabis cultivars from the uniqu...
https://www.queenslandbauxite.com/single-post...edications
Read More: https://investorshangout.com/post/view?id=496...z5AcAA6sPD
(0)
(0)
Robert
